National brain tumour research funding needs to increase to £35 million a year
Tessa Jowell Brain Cancer Mission announces first Fellowship appointments
The Tessa Jowell Brain Cancer Mission has announced the appointment of the two first fellows to its inaugural Tessa Jowell Fellowship programme.
Dr Morag Brothwell and Dr Sean Main will complete a 12-month programme of high-quality training in neuro-oncology clinical practice and research. The new fellows will be hosted at two Tessa Jowell Centres of Excellence: King’s Health Partners and University College London Hospital.
The programme will train these highly skilled clinicians to appreciate the breadth of comprehensive brain tumour management and equip them with the research skills to lead high impact, practice-changing neuro-oncology clinical trials of the future. The Fellowship programme, led by the Tessa Jowell Brain Cancer Mission, is co-funded by the National Institute for Health and Care Research (NIHR) and the Tessa Jowell Foundation (TJF).
Dr Nicky Huskens, Chief Executive Officer of the Tessa Jowell Brain Cancer Mission, said: “We are delighted to welcome two fellows to the Tessa Jowell Fellowship programme. Through the training and research they plan to undertake, they will make a positive contribution to the thriving brain tumour research efforts in the UK and support patients affected by this devastating disease.”
By combining its resources and expertise with those of the NIHR and charity sector, the Mission hopes to address workforce and skills shortages in the brain tumour field. It is hoped that the fellowship programme will expand to include fellows from other specialties including neuroradiologists, pathologists and allied health professionals in future rounds.
Dr Karen Noble, our Director of Research, Policy and Innovation, said: “Our congratulations to Dr Brothwell and Dr Main on their appointment as fellows, and to the Mission on this exciting initiative. We look forward to seeing how the programme helps to attract top talent and drive innovation in brain cancer treatment and research, and how it complements the work we are doing to build capacity and increase investment in brain tumour research in the UK in order to improve outcomes and, ultimately, find a cure.”
- Tessa Jowell Brain Cancer Mission
- Read about the novel therapeutics initiative we fund in partnership with the Mission
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.